Hello, and welcome to the Stratasys Q1 2021 Conference Call and Webcast. [Operator Instructions]
It is now my pleasure to turn the call over to Yonah Lloyd, Vice President, Investor Relations. Please go ahead.
Yonah Lloyd
Vice President of Investor Relations
Good morning everyone, and thank you for joining us to discuss our 2021 first quarter financial results. On the call with us today are our Chief Executive Officer, Dr. Yoav Zeif; and our Chief Financial Officer, Lilach Payorski. I remind you that access to today s call, including the slide presentation is available online at the web address provided in our press release. In addition, a replay of today s call including access to the slide presentation will also be available and can be accessed through the Investor Relations section of our website.
Operator
Good afternoon, everyone, and welcome to the nLIGHT First Quarter 2021 Earnings Conference Call. [Operator Instructions] Please also note, today s event is being recorded.
At this time, I d like to turn the conference call over to Joseph Corso, Vice President, Corporate Development and Investor Relations. Sir, please go ahead.
Joseph Corso
Vice President, Corporate Development and Investor Relations
Thank you, and good afternoon, everyone. With us today are Scott Keeney, nLIGHT s Chairman and CEO; and Ran Bareket, Chief Financial Officer.
Today s discussion will contain forward-looking statements, including financial projections and plans for our business. Forward-looking statements are subject to risks and uncertainties, many of which are beyond our control, including the risks and uncertainties described from time to time in our SEC filings. Our results may differ materially from those projected on today s call, and we undertake no obligation to update publicly an
Operator
Greetings. Welcome to the Proto Labs Q1 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].
I will now turn the conference over to your host, Dan Schumacher. Mr. Schumacher, you may begin.
Dan Schumacher
Director of Investor Relations and Financial planning and analysis
Thank you, Alex, and good morning, everyone. With me today are Rob Bodor, Proto Labs President and Chief Executive Officer; and John Way, our Chief Financial Officer. This morning, Proto Labs issued a press release announcing its financial results for the first quarter ended March 31, 2021. The release is available on the company s website. In addition, a prepared slide presentation is available online at the web address provided in our press release. Before we begin, I would like to remind everyone that our discussion will include statements relating to future performance a
Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering
HIGHLANDS RANCH, Colo., May 06, 2021 (GLOBE NEWSWIRE) Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced the pricing of its underwritten follow-on public offering of 4,000,000 shares of its common stock at a public offering price of $6.00 per share.
The aggregate gross proceeds to Vivos from the public offering are expected to be $24 million prior to deducting underwriting discounts, commissions, and other estimated offering expenses. Vivos has granted the underwriters a 45-day option to purchase up to an additional 600,000 shares of common stock to cover over-allotments, if any.
Operator
Good day, and welcome to the II-VI fiscal Q3 earnings conference call. Today s conference is being recorded. At this time, I would like to turn the conference over to Mary Jane Raymond, chief financial officer. Please go ahead.
Mary Jane Raymond
Chief Financial Officer
Thank you, Shelby, and good morning. I am Mary Jane Raymond, the chief financial officer here at II-VI Incorporated. Welcome to our earnings call today for the third quarter of fiscal year 21. With me today on the call are Dr.
Chuck Mattera, our chief executive officer; and Dr. Giovanni Barbarossa, our chief strategy officer and the president of the compound semiconductor segment. This call is being recorded on Thursday, May 6, 2021. Our press release and our updated investor presentation are available on the investor relations tab of the website, ii-vi.com.